Hunners Lesion Case Study

1. van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60–67.[PubMed]

2. Chancellor MBA. Multidisciplinary consensus meeting on IC/PBS: outcome of the consensus meeting on interstitial cystitis/painful bladder syndrome. Rev Urol. 2007;9:81–83.[PMC free article][PubMed]

3. Parsons JK, Parsons CL. The historical origins of interstitial cystitis. J Urol. 2004;171:20–22.[PubMed]

4. Hunner GL. A rare type of bladder ulcer in women: report of cases. Boston Med Soc J. 1915;172:247–292.

5. Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol. 1998;160:1663–1667.[PubMed]

6. Engeler D, Baranowski AP, Borovicka J, et al. EAU Guidelines on Chronic Pelvic Pain. Uroweb; 2014.

7. Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173:98–102.[PubMed]

8. Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology. 1997;49:2–9.[PubMed]

9. Miller JL, Rothman I, Bavendam TG, Berger RE. Prostatodynia and interstitial cystitis: one and the same? Urology. 1994;45:587–590.[PubMed]

10. Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189:141–145.[PMC free article][PubMed]

11. Warren JW, Jackson TL, Langenberg P, Meyers DJ, Xu J. Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. Urology. 2004;63:17–21.[PubMed]

12. Allen-Brady K, Norton PA, Cannon-Albright L. Risk of associated conditions in relatives of subjects with interstitial cystitis. Female Pelvic Med Reconstr Surg. 2014;21(2):93–98.[PMC free article][PubMed]

13. Domschke K, Maron E. Genetic factors in anxiety disorders. Mod Trends Pharmacopsychiatri. 2013;29:24–46.[PubMed]

14. Gheinani AH, Burkhard FC, Monastyrskaya K. Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome. Cell Mol Life Sci. 2013;70(20):3773–3789.[PubMed]

15. Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil. 2013;19(3):301–311.[PMC free article][PubMed]

16. Martínez-Martínez LA, Mora T, Vargas A, Fuentes-Iniestra M, Martínez-Lavín M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol. 2014;20(3):146–150.[PubMed]

17. Smorgick N, Marsh CA, As-Sanie S, Smith YR, Quint EH. Prevalence of pain syndromes, mood conditions, and asthma in adolescents and young women with endometriosis. J Pediatr Adolesc Gynecol. 2013;26(3):171–175.[PubMed]

18. Logadottir Y, Delbro D, Lindholm C, Fall M, Peeker R. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis. Int J Urol. 2014;21(suppl 1):75–78.[PubMed]

19. Bicer F, Altuntas CZ, Izgi K, et al. Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model. Am J Physiol Renal Physiol. 2014;10 ajrenal.00202. [PMC free article][PubMed]

20. Izgi K, Altuntas CZ, Bicer F, et al. Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice. PLoS One. 2013;8(8):e72067.[PMC free article][PubMed]

21. Rosen JM, Klumpp DJ. Mechanisms of pain from urinary tract infection. Int J Urol. 2014;21(suppl 1):26–32.[PMC free article][PubMed]

22. Verit A, Güner ND. Helicobacter pylori and urinary system stones: endoluminal damage as sub-hypothesis to support the current stone theory. Med Hypotheses. 2014;83(6):677–680.[PubMed]

23. Chen HM, Lin CC, Kang CS, Lee CT, Lin HC, Chung SD. Bladder pain syndrome/interstitial cystitis increase the risk of coronary heart disease. Neurourol Urodyn. 2014;33(5):511–515.[PubMed]

24. Lee WY, Savage JR, Zhang J, Jia W, Oottamasathien S, Prestwich GD. Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan. PLoS One. 2013;8(10):e77854.[PMC free article][PubMed]

25. Keay S. Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal. 2008;20:2174–2179.[PubMed]

26. Teichman JM, Moldwin R. The role of the bladder surface in interstitial cystitis/painful bladder syndrome. Can J Urol. 2007;14(4):3599–3607.[PubMed]

27. Lee JD, Lee MH. Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome. J Formos Med Assoc. 2014;113(1):17–22.[PubMed]

28. Yoshikawa S, Kawamorita N, Oguchi T, et al. Pelvic organ cross-sensitization to enhance bladder and urethral pain behaviors in rats with experimental colitis. Neuroscience. 2015;284:422–429.[PubMed]

29. Warren JW. Bladder pain syndrome/interstitial cystitis as a functional somatic syndrome. J Psychosom Res. 2014;77(6):510–515.[PubMed]

30. Buffington CAT. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol. 2004;172:1242–1248.[PubMed]

31. Warren JW, Wesselmann U, Morozov V, Langenberg PW. Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. Urology. 2011;77(2):313–319.[PubMed]

32. Peters KM, Killinger KA, Mounayer MH, Boura JA. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. Urology. 2011;78(2):301–308.[PubMed]

33. Nickel JC, Tripp DA, Pontari M, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol. 2010;184(4):1358–1363.[PubMed]

34. Parsons CL. Diagnosing the bladder as the source of pelvic pain: successful treatment for adults and children. Pain Manag. 2014;4(4):293–301.[PubMed]

35. Marsha KG, Toby CC. Interstitial cystitis/painful bladder syndrome (IC/PBS): is there anything new under the sun? Curr Obstet Gynecol Rep. 2014;3:165–171.

36. Clemens JQ, Clauw DJ, Kreder K, et al. MAPP Research Network Comparison of baseline urologic symptoms in men and women in the multidisciplinary approach to the study of chronic pelvic pain (Mapp) research cohort. J Urol. 2014;193(5):1554–1558.[PMC free article][PubMed]

37. Liu B, Su M, Zhan H, Yang F, Li W, Zhou X. Adding a sexual dysfunction domain to upoint system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome. Urology. 2014;84(6):1308–1313.[PubMed]

38. Quaghebeur J, Wyndaele JJ. Prevalence of lower urinary tract symptoms and level of quality of life in men and women with chronic pelvic pain. Scand J Urol. 2014;2:1–8.[PubMed]

39. Nickel JC, Irvine-Bird K, Jianbo L, Shoskes DA. Phenotype-directed management of interstitial cystitis/bladder pain syndrome. Urology. 2014;84(1):175–179.[PubMed]

40. Krieger JN, Stephens AJ, Landis JR, et al. MAPP Research Network Relationship between chronic non-urological associated somatic syndromes (NUAS) and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the multidisciplinary approach to the study of chronic pelvic pain (MAPP) study. J Urol. 2015;193(4):1254–1262.[PMC free article][PubMed]

41. Qu HC, Zhang W, Yan S, Liu YL, Wang P. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis. PLoS One. 2014;9(9):e106321.[PMC free article][PubMed]

42. Bhide AA, Cartwright R, Khullar V, Digesu GA. Biomarkers in overactive bladder. Int Urogynecol J. 2013;24(7):1065–1072.[PubMed]

43. Jiang YH, Liu HT, Kuo HC. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid. PLoS One. 2014;9(3):e91609.[PMC free article][PubMed]

44. Yang W, Kim Y, Kim TK, et al. Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo. BJU Int. 2012;110(11 pt C):E1138–E1146.[PMC free article][PubMed]

45. Rubio-Diaz DE, Pozza ME, Dimitrakov J, et al. A candidate serum biomarker for bladder pain syndrome/interstitial cystitis. Analyst. 2009;134(6):1133–1137.[PMC free article][PubMed]

46. Hsieh TF, Yu KJ, Lin SY. Possible application of Raman microspectroscopy to verify the interstitial cystitis diagnosis after potassium sensitivity test: phenylalanine or tryptophan as a biomarker. Dis Markers. 2007;23(3):147–152.[PMC free article][PubMed]

47. Hackshaw KV, Rodriguez-Saona L, Plans M, Bell LN, Buffington CA. A bloodspot-based diagnostic test for fibromyalgia syndrome and related disorders. Analyst. 2013;138(16):4453–4462.[PubMed]

48. Wen H, Lee T, You S, et al. Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkers. J Proteome Res. 2014;14(1):541–548.[PMC free article][PubMed]

49. Towner RA, Smith N, Saunders D, et al. Contrast-enhanced magnetic resonance imaging (CE-MRI) as a diagnostic tool for assessing bladder permeability and associated colon cross-talk: pre-clinical studies in a rat model. J Urol. 2014;193(4):1394–1400.[PMC free article][PubMed]

50. Patel BN, Evans RJ. Overactive bladder and pain: management strategies. Curr Urol Rep. 2010;11(6):379–384.[PubMed]

51. Hanno PM, Burks DA, Quentin Clemens J. Diagnosis and Treatment of Interstitial Cystitis/Bladder pain Syndrome. American Urological Association (AUA) Guideline; 2014. [PubMed]

52. Leong FC. Complementary and alternative medications for chronic pelvic pain. Curr Pain Headache Rep. 2011;15(5):343–346.[PubMed]

53. Hoffman D. Understanding multisymptom presentations in chronic pelvic pain: the inter-relationships between the viscera and myofascial pelvic floor dysfunction. Obstet Gynecol Clin North Am. 2014;41(3):503–510.[PubMed]

54. Hartmann D, Sarton J. Chronic pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):977–990.[PubMed]

55. Pergialiotis V, Arnos P, Mavros MN, Pitsouni E, Athanasiou S, Falagas ME. Urinary tract analgesics for the treatment of patients with acute cystitis: where is the clinical evidence? Expert Rev Anti Infect Ther. 2012;10(8):875–879.[PubMed]

56. van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172:533–536.

Study Seeking Women Who Suffer from IC with Hunner’s Lesions

Do you or someone you know suffer from IC with Hunner’s Lesions? If so, you are familiar with the pain that can make it difficult to enjoy life. Allergan, Inc. is enrolling participants for a research study investigating a drug device to evaluate the safety and effectiveness of a continuous release of lidocaine inserted into the bladder compared with placebo for the symptoms of IC with Hunner’s Lesions in female patients. All patients will have the opportunity to receive the active study drug if they request and satisfy the criteria.

Click here to learn more.

The Interstitial Cystitis Association (ICA) advocates for interstitial cystitis (IC) research dedicated to discovery of a cure and better treatments, raises awareness, and serves as a central hub for the healthcare providers, researchers and millions of patients who suffer with constant urinary urgency and frequency and extreme bladder pain called IC. Below please find a notice for a research study being conducted by Allergan that we thought may be of interest to you.

ICA is providing this information as a service and is neither sponsoring nor conducting this research study. ICA does not have any participation in determining the acceptance criteria or in selecting study participants. ICA’s sole intent is to make potentially eligible participants aware of this study being conducted by Allergan. Should you have any questions regarding the study, please contact the study coordinator directly.

0 Replies to “Hunners Lesion Case Study”

Lascia un Commento

L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *